CGRP receptor antagonists
    3.
    发明授权
    CGRP receptor antagonists 有权
    CGRP受体拮抗剂

    公开(公告)号:US07659264B2

    公开(公告)日:2010-02-09

    申请号:US11664905

    申请日:2005-10-05

    摘要: The present invention is directed to compounds of Formula I: Formula I: I and Formula II: (where variables R1, R2, R3, R4, A, B, J, Q, T, V, W, X and Y are as defined herein) useful as antagonists of CGRP receptors and useful in the treatment or prevention of diseases in which the CGRP is involved, such as headache, migraine and cluster headache. The invention is also directed to pharmaceutical compositions comprising these compounds and the use of these compounds and compositions in the prevention or treatment of such diseases in which CGRP is involved.

    摘要翻译: 本发明涉及式I化合物:式I:I和式II(其中变量R1,R2,R3,R4,A,B,J,Q,T,V,W,X和Y如上所定义 可用作CGRP受体的拮抗剂,可用于治疗或预防涉及CGRP的疾病,例如头痛,偏头痛和丛集性头痛。 本发明还涉及包含这些化合物的药物组合物以及这些化合物和组合物在预防或治疗涉及CGRP的疾病中的用途。

    Phenyl-protein transferase inhibitors
    6.
    发明授权
    Phenyl-protein transferase inhibitors 失效
    苯基蛋白转移酶抑制剂

    公开(公告)号:US06333335B1

    公开(公告)日:2001-12-25

    申请号:US09609205

    申请日:2000-06-30

    IPC分类号: A61K31437

    CPC分类号: C07D471/04

    摘要: The present invention is directed to tetrahydro-imidazopyridinyl compounds which inhibit prenyl-protein transferase and the prenylation of the oncogene protein Ras. The invention is further directed to chemotherapeutic compositions containing the compounds of this invention and methods for inhibiting prenyl-protein transferase and the prenylation of the oncogene protein Ras.

    摘要翻译: 本发明涉及抑制异戊烯基 - 蛋白质转移酶和癌基因蛋白Ras的异戊烯化的四氢 - 咪唑并吡啶基化合物。 本发明还涉及含有本发明化合物的化疗组合物和抑制异戊烯基 - 蛋白质转移酶和癌基因蛋白Ras的异戊烯化的方法。